ResearcherShanghai Jiao Tong UniversityActive in the last 2 years
Ruimeng Yang
Matched on ORCID iD 0000-0003-2768-9429; OpenAlex author ID A5012755658. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 2 papers
Papers 7
- Diagnostic utility of p53, SMAD4, and the novel biomarker PON2 in FNA of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/cncy.70058↗
- Morphological characterization of atypical pancreatic ductal adenocarcinoma with cystic lesion on DCE-CT: a comprehensive retrospective study. Last author DOI 10.1186/s12880-025-01586-4↗
- The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation. Co-author DOI 10.1016/j.ebiom.2020.103195↗
- miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6. Co-author DOI 10.1080/15384101.2020.1831254↗
- Elevated expression of NFE2L3 predicts the poor prognosis of pancreatic cancer patients. Co-author DOI 10.1080/15384101.2018.1520558↗
- miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis. Co-author DOI 10.1038/cddis.2017.530↗
- miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer. Co-author DOI 10.1186/s12943-017-0723-7↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ming Zhan · 5 shared papers, 2017–2021 · strength 0.47
- Paper The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation. DOI 10.1016/j.ebiom.2020.103195↗
- Paper miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6. DOI 10.1080/15384101.2020.1831254↗
- Paper Elevated expression of NFE2L3 predicts the poor prognosis of pancreatic cancer patients. DOI 10.1080/15384101.2018.1520558↗
- Guoping Cai · 1 shared paper, 2025 · strength 0.33
- Linhua Yang · 3 shared papers, 2017–2021 · strength 0.31
- Paper The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation. DOI 10.1016/j.ebiom.2020.103195↗
- Paper miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6. DOI 10.1080/15384101.2020.1831254↗
- Paper miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EM… DOI 10.1038/cddis.2017.530↗
- Jing Chen · 1 shared paper, 2025 · strength 0.28
- Manmei Long · 3 shared papers, 2017–2020 · strength 0.24
- Paper miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6. DOI 10.1080/15384101.2020.1831254↗
- Paper miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EM… DOI 10.1038/cddis.2017.530↗
- Paper miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer. DOI 10.1186/s12943-017-0723-7↗
- Jian Wang · 3 shared papers, 2017–2018 · strength 0.23
- Paper Elevated expression of NFE2L3 predicts the poor prognosis of pancreatic cancer patients. DOI 10.1080/15384101.2018.1520558↗
- Paper miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EM… DOI 10.1038/cddis.2017.530↗
- Paper miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer. DOI 10.1186/s12943-017-0723-7↗
- Qiang Liu · 2 shared papers, 2017 · strength 0.13
- Yongwei Sun · 1 shared paper, 2021 · strength 0.13
- Xing Liang · 1 shared paper, 2021 · strength 0.13
- Hui Wang · 1 shared paper, 2020 · strength 0.11
- Rong Yue Cao · 1 shared paper, 2020 · strength 0.11
- Hui Wang · 1 shared paper, 2018 · strength 0.10
- Shuai Huang · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.